Skip to main content

Find Clinical Trials

Home
Conditions
Follicular Lymphoma

Clinical trial condition

Follicular Lymphoma

Explore clinical trials studying Follicular Lymphoma. Study availability and eligibility vary by location and protocol.

233 public trials 71 recruiting studies

Refine in advanced search Browse all conditions

Follicular Lymphoma trial results

Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Conditions: Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
Locations: City of Hope Cancer Center Duarte, California, United States

University of California San Diego Medical Center La Jolla, California, United States

University of California Los Angeles Los Angeles, California, United States

St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States

View all 175 locations

View Trial Details

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT05805605

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma

NCT03501576

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +25 more
Locations: Emory University Hospital Midtown Atlanta, Georgia, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

NCT06860880

Conditions: Behavior, Blood Protein Disorders, Cardiovascular Diseases, +37 more
Locations: North Carolina Basnight Cancer Hospital Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT03314974

Conditions: Acquired Bone Marrow Failure Syndromes, Acute Leukemia, Acute Lymphoblastic Leukemia, +74 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

NCT04545762

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

Evaluation of Skin Tests in Biotherapy Allergies

NCT06971848

Conditions: AL Amyloidosis, Adenocarcinoma, Adenoma, +75 more
Locations: CHU Angers Angers, France

View Trial Details

Recruiting

64Cu-LLP2A for Imaging Hematologic Malignancies

NCT06636175

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Recruiting

Mosunetuzumab and Zeprumetostat in Treating Patients With Follicular Lymphoma

NCT07555470

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

NCT06131801

Conditions: ALL, AML, Acute Lymphocytic Leukemia, +50 more
Locations: Children's Hospital Colorado Aurora, Colorado, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details